Natco partner’s multiple sclerosis injection receives USFDA approval
The US Food and Drug Administration(USFDA), has given approval to Natco Pharma’s marketing partner,Mylan’s Glatiramer Acetate injection used for treating relapsing forms of multiple sclerosis(MS)....